Table 1.
Distribution of Clinical, Biochemical, Radiological, and Pathological Data of Patients Included in the Study.
| Baseline Characteristics | Distribution (n = 50) |
|---|---|
| Age | 55.64 ± 7.866 |
| Gender | |
|
42 (84.0%) |
|
8 (16.0%) |
| Child-Turcotte-Pugh class | |
|
24 (48.0%) |
|
26 (52.0%) |
| Hemoglobin concentration (g/dL) | 12.12 ± 1.554 |
| Platelet count (×103/cmm) | 118.36 ± 55.650 |
| Leucocyte count (×103/cmm) | 5.74 ± 1.858 |
| Serum aspartate aminotransferase (U/L) | 80.36 ± 54.588 |
| Serum alanine aminotransferase (U/L) | 65.88 ± 28.400 |
| Serum Albumin (g/dL) | 3.08 ± 0.374 |
| Serum Bilirubin (mg/dL) | 1.40 ± 0.475 |
| Prothrombin activity (%) | 70.38 ± 11.450 |
| Serum alpha-fetoprotein (ng/dL) | 152.78 ± 313.132 |
| Number of tumors | |
| Mean value | 1.46 ± 0.706 |
| Distribution: | |
| 1 nodule | 33 (66.0%) |
| 2 nodules | 11 (22.0%) |
| ≥3 nodules | 6 (12.0%) |
| Size of tumors | |
| Mean value | 3.25 ± 0.892 |
| Distribution: | |
| <2 cm | 3 (6.0%) |
| 2–3 cm | 20 (40.0%) |
| >3 cm–≤5 cm | 24 (54.0%) |
| Pathological grade of tumors | |
| Grade I (well-differentiated) | 9 (18.0%) |
| Grade II (moderately-differentiated) | 31 (62.0%) |
| Grade III (poorly-differentiated) | 10 (20.0%) |